Eyenovia's - EYEN market analysis on 24th January 2021

Transaction Date	Recipient	Shares	Type	Price	Value
15th January 2021	Ernest Mario	41,216	Exercise of in-the-money or at-the-money derivatives securities (usually options)	$2.27	$93,560.32
2nd December 2020	Anthony Y Sun	7,878	Open or private sale	$51.67	$407,021.60
2nd December 2020	Anthony Y Sun	6,283	Open or private sale	$52.70	$331,122.90
2nd December 2020	Anthony Y Sun	3,411	Open or private sale	$49.79	$169,838.12
2nd December 2020	Anthony Y Sun	9,222	Open or private sale	$50.90	$469,361.07
24th November 2020	Anthony Y Sun	100	Open or private sale	$47.56	$4,756.00
24th November 2020	Anthony Y Sun	5,831	Open or private sale	$46.21	$269,424.27
24th November 2020	Anthony Y Sun	5,455	Open or private sale	$46.68	$254,663.95
23rd November 2020	Anthony Y Sun	1,712	Open or private sale	$47.19	$80,791.51
23rd November 2020	Anthony Y Sun	13,696	Open or private sale	$46.45	$636,128.52

Eyenovia

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.

Edenovia, Inc. engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine.

Ticker: EYEN

Sector: Healthcare

Industry: Biotechnology

SEC Central Index Key (CIK): 1682639

Employees: 24

Exchange: NASDAQ

Auditor Opinion:

You must Login to see Language Changes

Disclosure Language changes

Analysis of subtle changes in disclosure language. Red is a sign of more constrained, less positive language changes etc. Green is more positive, less constrained etc.

You must Login to see analysis